Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation.

Ganoderma lucidum

OncologyImmune supportCognition & nervesEnergy & fatigue

SpeciesReishi, Lingzhi

JournalMetabolic brain disease

Year2025

Metadata-grounded summary

Article summary

Metadata-grounded summary: This journal article indexes research on Ganoderma lucidum in Metabolic brain disease in 2025. MycoData maps the paper to oncology, immune support, cognition & nerves, energy & fatigue based on its title, species context, article metadata, and study classification.

Citation

Liu X, Li Y, Wang J, Meng T, Song L, Yang L, et al. (2025). Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation. Metabolic brain disease https://doi.org/10.1007/s11011-025-01601-1 PMID: 40227285

Open citation